SCHEMBL4018141

SCHEMBL4018141

NC(=O)c1ccc(Oc2c(F)cc(CNC3CCCCC3)cc2F)cc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.44
CHEK1 O14757 1/20 0.41
PABPC1 P11940 1/20 0.40
KMT2A Q03164 2/20 0.40
PARP15 Q460N3 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
MITF O75030 2/20 0.39
MAPT P10636 2/20 0.39
PKM P14618 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
XBP1 P17861 1/20 0.39
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC1 Q13547 1/20 0.38
POLB P06746 1/20 0.36
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020004 0.87 FYN (0.42) PARP10PARP15ALDH1A1KDM4ELMNA
SCHEMBL4018676 0.86 PARP10 (0.41) PARP10KMT2APARP15MEN1ALDH1A1
SCHEMBL4016203 0.80 PARP10 (0.39) PARP10PARP15SCN9AOPRK1
SCHEMBL4018667 0.79 FPR2 (0.39) PARP10PARP15SCN9A
SCHEMBL4018367 0.79 ATM (0.44) KMT2AMEN1ALDH1A1KDM4EPKM
SCHEMBL4018723 0.77 OPRM1 (0.41) PARP10PARP15SCN9AOPRK1
SCHEMBL4024269 0.76 LMNA (0.42) LMNAHDAC1HTTOPRK1
SCHEMBL4014221 0.75 MEN1 (0.36) PARP10KMT2APARP15MEN1MITF
SCHEMBL4019651 0.75 PARP10 (0.40) PARP10KMT2APARP15MEN1LMNA
SCHEMBL12316318 0.69 PARP10 (0.55) PARP10PARP15ALDH1A1MAPK1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US claimed
EP-2064199-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF Pfizer Products Inc. (US) 2009-06-03 EP claimed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US claimed
WO-2008032156-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF PFIZER PRODUCTS INC. (US) 2008-03-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof OPRD1, OPRK1, OPRL1 PARP10 2285/4885CHEK1 4844/4885PABPC1 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.